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Polymer based nanofibers using ethylene-co-vinyl alcohol (EVOH) were fabricated by electrospinning technology. The nanofibers
were studied for potential use as dressingmaterials for skinwounds treatment. Properties closely related to the clinical requirements
for wound dressing were investigated, including the fluid uptake ability (FUA), the water vapour transmission rate (WVTR), the
bacteria control ability of nanofibers encapsulated with different antibacterial drugs, and Ag of various concentrations. Nanofibre
degradation under different environmental conditions was also studied for the prospect of long term usage. The finding confirms
the potential of EVOH nanofibers for wound dressing application, including the superior performance compared to cotton gauze
and the strong germ killing capacity when Ag particles are present in the nanofibers.
1. Introduction
1
Skin wounds and their treatment are significant health
problems [1–3]. The dressing material plays a key role in
treatment and recovery, providing surface protection, tissue
and cell restriction, moisture maintaining, air permeability,
bacteriostatic controlling activities, drug delivery, and other
functions [4, 5]. Electrospinning, also known as electrostatic
spinning, is a popular method to fabricate nonwoven fibers
with different shapes and sizes [6, 7]. It is currently the2
only method to prepare fabric of fibers with diameters down
to a few nanometers [8]. Fibrous materials of submicron3
dimensions are potentially better candidates in skin wound
treatment than normal dressing materials such as cotton
pads and bandages due to a number of advantageous fea-
tures, including high porosity ratio, high permeability and
mechanical strength, and biocompatibility and biodegrad-
ability, among others [9–12]. A number of methods have
also been developed to add drugs into the electrospinning
process so the nanofibers obtained become carriers [13] for
the additional function of anti-inflammation [14]. EVOHwas
selected for this study due to its good biocompatibility and
proven usage in nanofibers preparation with electrospinning
[15–17].
In a previous study [18], we presented a method to fab-
ricate poly (ethylene-co-vinyl alcohol) (EVOH) nanofibers
encapsulated with Ag nanoparticle using electrospinning
technique. The fibers were fabricated with controlled diame-
ters (59 nm - 3 𝜇m) by regulating three main parameters, that
is, EVOH solution concentration, the electric voltage, and the
distance between the injection needle tip (high voltage point)
and the fiber collector. The study showed the relationship
between the electrospinning fabrication parameters and the
properties of the fibers produced, such as the diameter
of the nanofibers, the regularity of the nanofiber shape,
the uniformity of the diameter, and the average length of
the uniform fiber. The mechanical strengths of nanofiber
2 Journal of Nanomaterials
Fibre
Needle
Collector
Spinning area
Pump
Polymer solution
Power supply
(0~30kV)
−
+
Figure 1: The electrospinning system.
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Figure 2: SEM image and TEM image of nanofibers contain Ag: (a)
SEM image, (b) TEM image.
mats under monotonic and cyclic tension loading were also
discussed [19].
In this study, we investigated the nanofibers’ properties
closely related to the clinical requirements for wound dress-
ing. The fluid uptake ability, the water vapour transmission
rates, the bacteria control ability of nanofibers encapsu-
lated with different antibacterial drugs and Ag of various
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Figure 3: The fluid uptake ability of different nanofibers (A, B, and
C) and cotton gauze (D).
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Figure 4: Changes of WVTR of nanofiber groups in terms of time.
concentrations, and the degradation of EVOH nanofibers
under different environmental conditions were investigated.
The study was entirely experiment based and is reported
in the following order in this paper. First, the materials
used were discussed, followed by a brief introduction on
the electrospinning process. The tests and results of fluid up
taking, water vapour transmission, and bacteria control were
then reported, followed by degradation results. Discussion on
the findings and conclusions were then provided in view of
the potential medical application.
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Figure 5: Bacteria test after 6 hours of incubation at 37∘C: (a) pure EVOH nanofiber and the rest are nanofibers containing (b) gentamicin
(60 k units in 10mL solution), (c) Ag nanoparticle (0.1 g in 10mL solution, and (d) iodine (0.1 g in 10mL solution).
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Figure 6: (a) Average diameter of bacterial loop, 6mm, indicates no antibacterial effect: (1) Pure EVOH nanofiber, (2) nanofiber containing
gentamicin, (3) nanofiber containingAg nanoparticle, and (4) nanofibers containing iodine. (b) Averaged bacteriostatic loop diameter plotted
as a function of Ag concentration.
2. Material and Electrospinning Process
2.1. Materials. Poly (ethylene-co-vinyl alcohol) (EVOH) was
used to make nanofibers in this study. The material was
ordered in granular form from Sigma-Aldrich (Batch num-
ber: 12822PE). Solid granules were diluted into solutions of
80% 2-propanol/water, in composition of EVOH from 7.5, 10,
and 12% (wt%) for injection use.4
For the antibiotics used in the study, AgNO3 was obtained
in powder form from Alfa Aesar (Alfa Aesar, 7761-88-8).
Iodine was purchased from Tianli (Tianli, AR/250 g) in pow-
der form. And gentamicin of a clinical grade was obtained
fromXi’an 1stHospital in the specification of 60000 units/mL.
Dosages of the antibiotics used in the experiments are
listed in Table 1 together with the carrier material EVOH.
Staphylococcus aureus, one of the main pathogenic bacteria
found on both animal and human wound surfaces [20, 21],
was chosen to test the antibacterial ability of the nanofibers.5
2.2. Experimental Procedure for Electrospinning of Nanofibers.
The electrospinning system (Figure 1) used for electrospin-
ning is an improved in-house platform developed in the
previous study [18, 22]. The system is composed of a high
voltage power supply with a low current output (Spellman
CZE1000R, 0–30 kV, maximum 0.1mA), a peristaltic pump
with a feeding capacity in the range of 1.0 to 15.0mL h−1
(Masterflex, 77120-52), and a feeding tube fixed with a fine
metal needle at the end. All nanofiber samples were prepared
from the solution of 7.5% (w/v) EVOH. Three bacterial
control agents, AgNO3, iodine, and gentamicin, were added
to EVOH solution, respectively. The solutions were then
injected at the speed of 2.5mL h−1 in a space field charged
to 25 kV to obtain the nanofibers through the spinning of the
jet. Table 1 lists the fabrication parameters of the three fiber
groups used in this study. 6
Fibers obtained in this study were in the diameter range
from 400 nanometers to 2.2 micron meters. Scanning elec-
tron microscopy (SEM) was performed to characterize the
dimension profile of the fibers obtained. Figure 2(a) shows
SEM image of the nanofibers obtained. Fibers are smooth
and randomly oriented, with an average diameter of 500 nm.
Figure 2(b) is a transmission electron microscopy (TEM)
image showing a local section of a fiber obtained from EVOH
solution containing AgNO3. Shaded dots distributed inside
the nanofibers are simple Ag particles according to an EDX
analysis [18].
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Figure 7: (a) Degradation of EVOH nanofiber in PBS solution. (b) UV degradation of nanofibers.
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Figure 8: (a) Original fine fiber sample before exposure to UV light, (b) fiber sample after 72 h continuous exposure to UV light, (c) SEM
image of EVOH fiber after 24 h UV exposure, and (d) SEM image of EVOH fiber after 72 h UV exposure.
Table 1: Materials.
Materials Provenience Dosage in the experiments
Poly Sigma-Aldrich 7.5% (0.75 g EVOH dissolved in 10mL 80% 2-propanol/water)
(ethylene-co-vinyl alcohol) (EVOH) (Batch number: 12822PE)
AgNO3 Alfa Aesar (Alfa Aesar, 7761-88-8) 0.1 g AgNO3 in 10mL EVOH solution
Iodine Tianli (Tianli, AR/250 g) 0.1 g in 10mL EVOH solution
Gentamicin Xi’an 1st Hospital 60 k units in 10mL EVOH solution
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Table 2: Sample descriptions of EVOH nanofibers.
Sample group Fabrication parameters Fibre diameter range
A 7.5% solution, 15 kV, 2.5mL/hr, 0.4–0.9 𝜇m
20 cm standing distance
B 10% solution, 15 kV, 2.5mL/hr, 0.8–1.5 𝜇m
20 cm standing distance
C 12% solution, 15 kV, 2.5mL/hr, 1.3–2.2 𝜇m
20 cm standing distance
Table 3: Irradiation strength of different light sources.
Light source Distance between the lightsource and the fibres/mm Wave length/nm Radiation strength/𝜇Wcm
−1
UV lamp 50.0 240–280 3.32 × 103
Daylight lamp 2000.0 400–700 0.19
Sunlight Ground, direct exposure 250–2500 49.9
3. Properties Related to Clinical Requirements
In this study, a few important features of the nanofibers were
considered for the potential application as a wound dressing
material, such as the fluid uptake ability (FUA) and the water
vapour transmission rates (WVTRs), which are important
characteristics in skin wound treatment. Such properties are
also significant in tissue engineering where the nanofibers
may also be used as scaffolding for cell growth and controlled
drug release.
For wound addressing, the bacteria control ability is
another key parameter, and new functionality can be devel-
oped for optimized application of antibacterial agents [23–
25]. Here, only a preliminary study was carried out using the
bacteriostatic loops to demonstrate the possibility of bacteria
control.
The degradation of nanofibers under environmental con-
ditions was also considered. Degradation tests in phosphate
buffer solution and under ultraviolet light were carried out,
providing an indication on the integrity of nanofiber mate-
rials in simulated human body conditions and accelerated
environment exposures.
3.1. Fluid Uptake Ability (FUA). The fluid uptake ability
(FUA) (%) of the nanofibers was calculated as a percentage
of water loss per unit weight:
FUA (%) =
(𝑊𝑠 −𝑊𝑑) × 100%
𝑊𝑠
, (1)
where𝑊𝑠 is the wet weight of the nanofiber and𝑊𝑑 is the dry
weight of the nanofiber.7
A piece of dry nanofiber mat (in room condition) was
first measured for its weight. It was then fully submerged into
distilled water for 15 seconds. The wet mat piece was picked
up and put on a fresh absorbing paper for 30 seconds, and its
weight was then measured again.
The FUA experimental data of the sample Groups A, B,
and C (categorized in Table 2) are given in Figure 3 compared
with those of normal medical cotton gauzes, denoted as
Group D (diameters of the cotton fibers are between 0.1 and
0.2mm). The result shows that all nanofiber groups have
a higher FUA (%) than that of cotton gauze. On average,
nanofibers can take 22% more water than cotton gauze per
unit weight.
Among the nanofiber groups, Group C has the highest
FUA at (85.97±0.7) %, while Group A has the lowest (81.66±
0.8)%, though the difference is only 5%. Figure 3 appears to
suggest that in the diameter range smaller than the micron
level, a lager diameter will lead to a higher FUA. But when
the fiber diameter is above the micron level, such as in cotton
gauze, FUA will drop with increased diameter.
3.2. Water Vapour Transmission Rates (WVTRs). The water
vapour transmission performance of the nanofiberswas mea-
sured in the following approach. Beakers filled with 5mL
distilled water were covered with a nanofiber mat of the
three sample groups, respectively. The covered beakers were
placed in an airtight environment chamber with saturated
ammonium sulfate solution. The weight of the beakers was
measured once every 24 hours over a period of 120 hours
(5 days). The difference of the measured weight was divided
by the cross-section area of the beaker. The water vapour
transmission rates, WVTRs (g⋅m−2 per day), were calculated
as the weight loss of water (gram) per evaporation exposure
area (m2) per day [26].
MeasuredWVTR of the nanofibers s is given in Figure 4,
showing that WVTR increases rapidly in Day 1. The 24-hour
measurement span means that there is only one data point
at the end of Day 1; thus, higher points which could occur
within Day 1 may have been missed. However, the tread
is captured. WVTR drops slightly from Day 1 and remains
virtually constant from Day 2 onwards with the values kept
in the range of 900 to 1000 g⋅m−2 per day. There is virtually
no difference between Groups A, B, and C. Group A has a
slightly higherWVTR, close to that of GroupD, which shows
the highest WVTR constantly, though marginally.
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3.3. Antibacterial Tests. To evaluate the clinical related per-
formance of the nanofibers, antibacterial tests were carried
out using culture dishes. Clear dishes were first covered
with LB culture mixed with Staphylococcus aureus (OD600
value: 1.1). One circular pad of 6mm diameter, cut from
each of the nanofiber samples containing Ag, iodine, and
gentamicin, respectively, and from pure EVOH nanofibers
with no antibacterial agent as the control group, was placed at
equal distance in a culture dish.The quantity of the antibiotic
agents contained in the nanofibers is, before electrospinning,
as follows:
gentamicin, 60 k units in 10mL solution;
Ag nanoparticle, 0.1 g AgNO3 in 10mL solution, and
iodine, 0.1 g in 10mL solution.
The culture dishes hosting the nanofiber pads were then
placed on a disk in a nursery box which was maintained at
37∘C.The disk was rotated continually inside the nursery box
at a constant rotational speed of frequency of 1Hz.
Figure 5 illustrates one of the culture dishes after 6 hours
of incubation at 37∘C, showing the four pads of samples
with pure EVOH fibres containing no antibacterial agent
marked as (a), and fibres containing gentamicin (b), Ag
nanoparticle (c), and iodine (d). While the disk is covered
by cultured Staphylococcus aureus seen in a foggy colour,
the clear shaded rings surrounding the pads (red circles
indicate the original pad size) are bacteriostatic loops where
Staphylococcus aureus had been eliminated. A bigger outer
ring diameter indicates stronger antibacterial effectiveness.
It can be clearly seen in Figure 5 that Ag (c) has the biggest
bacteriostatic loop while pure EVOH (a) and gentamicin (b)
show limited effectiveness.
Figure 6(a) shows the measured outer diameters of the
bacteriostatic loops. Nanofibers containing Ag nanoparticles
demonstrate the strongest germ killing capacity and the outer
diameter of its bacteriostatic loop is 58, 174, and 420%,
which is bigger than the one of iodine, gentamicin, and pure
EVOH, respectively. Consequently, only the influence of the
Ag density was further examined. Nanofibers using solutions
dissolved with different weight of AgNO3 were produced
and used for antibacterial tests. Figure 6(b) illustrates the
outer diameter of the bacteriostatic ring as a function of the
weight of Ag content in the nanofibers, measured in grams
per milliliter. The test set-up remained the same except the
culture time which was increased to 12 hours for this Ag
effectiveness study. As seen in Figure 6(b), the bacteriostatic
effectiveness shows approximately a power law relation to the
Ag density in the nanofibers.
4. Degradation of EVOH Nanofibers
The integrity of nanofibers under environmental elements
during production, storage, transportation, and usage is an
important factor for the application. To investigate this,
hydrolysis tests and ultraviolet light exposure tests were
performed. For the hydrolysis tests, nanofiber samples were
submerged in phosphate buffer solution (PBS) of pH value
of 7.2 and kept at 37∘C. The test was aimed to evaluate
time-based stability of the material in simulated in vivo
conditions. The samples were weighted every 72 hours with
a bioelectronic balance after 30mins of drying at 37∘C.
The ultraviolet exposure tests were performed in a pho-
tochemical reaction chamber. The irradiation strength of the
light at 240–280 nm wavelengths was 3.23 × 103 𝜇Wcm−2
as measured with a UV radiometer at the point where
the samples were placed. The samples were weighted and
photographed every 24 hours of exposure. 8
Hydrolysis in vitro shows that the nanofibers hardly
decompose in the simulated body environment. As shown
in Figure 7(a), only 2% weight change of the samples was
recorded after being submerged in PBS solution for 168
hours (7 days). Also, little degradation was observed. These
indicate good integrity of the nanofibers for long term use in
the human body condition, an importance requirement on
dressing materials. 9
In contrast to the hydrolysis tests, significant weight loss
and fiber break-up were observed during the UV exposure
tests (see Table 3 for comparable light exposures). Figure 7(b)
shows theweight variation of the nanofibers with andwithout
Ag nanoparticles versus the UV exposure hours. It can be
seen that the nanofibers degrade approximately linearly in
terms of the exposure duration. And those containing Ag
nanoparticles degrade faster with more than 40% weight
reduction over 72 hours (3 days) of exposure, twice theweight
loss in pure EVOH nanofibers.
In the format of the degradation, nanofibers show strong
signs of disintegration with shrinkage and break-down into
pieces, as shown in Figure 8. Figures 8(a) and 8(b) provide
a graphic revelation on nanofibers’ texture deterioration
under UV exposure. The relatively short duration for almost
complete structural destruction just over 72 hours indicates
a high sensitivity to UV lights. SEM images (Figures 8(c)
and 8(d)) show nanofibers breaking up and thinning out,
resulting in fabric structural destruction.
To further study the light sensitivity of the nanofibers, the
effects of exposure to different light sources were compared.
The irradiations of an UV lamp, a daylight lamp, and direct
sunlight were compared. In Table 2, the irradiation strength
of an UV lamp is 66 times stronger than that of the
direct sunlight exposure. Results of degradation under UV
lamp indicate that the nanofibers show signs of deteriorated
structures after 24 hours and are largely destroyed after 72
hours. This is equivalent to about half a year of exposure to
direct sunlight.
The high sensitivity in EVOH nanofibers degradation
under UV exposure leads to two interesting features. Firstly,
the UV light may be used as a mechanism to speed up
the release of Ag nanoparticles and possibly other drugs,
through the material break-up of the nanofibers when they
are used as a carrier. Secondly, the rapid texture deterioration
under UV lighting also means there would be implications
in using the EVOH nanofibers as wound dressing or bandage
for a prolonged period, where some UV shielding might be
required.
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5. Conclusions
The EVOH nanofibers were obtained in this study from an
electrospinning process. Experimental studies carried out
in the lab on some of the performance related to clinical
applications have led to the following conclusions.
(1) The electrospinning process does not inactivate the
antibacterial ability of encapsulated agents.
(2) Nanofibers show a good fluid uptake ability (FUA),
taking 22% more water than cotton gauze per unit
weight.
(3) Nanofibers’ water vapour transmission rates
(WVTRs) are comparable to those of cotton
gauze.
(4) Nanofibers containing silver particles demonstrate a
superior antibacterial capacity than those containing
gentamicin and iodine.
(5) The rapid degradation of nanofibers indicates that
shielding of UV exposure might be needed for
prolonged usage, but the feature may be used for
controlled drug release.
(6) Nanofibers are found to be stable in vitro condition,
thus potentially a good candidate for wound dressing
applications.
Based on the outcome of the study, we can draw the
conclusion that EVOHnanofibers are potentially a promising
candidate for skin wound dressing. In particular, the drug
carrying and slow release functions can be further explored
for optimal usage. As the study was based on a small quantity
of samples, results may be affected by random factors,
though care was taken to eliminate noticeable uncertainties.
However, more tests are needed on a large quantity and in a
broader scope and wider range of parameters. These will be
addressed in the continuity of this research programme.
Nomenclature
EVOH: Poly (ethylene-co-vinyl alcohol)
FUA: Fluid uptake ability
PBS: Phosphate buffer solution
SEM: Scanning electron microscopy
TEM: Transmission electron microscopy
UV: Ultraviolet
WVTR: Water vapour transmission rates (WVTRs)
𝑊𝑠: Wet weight of the nanofiber
𝑊𝑑: The dry weight of the nanofiber.
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